Lanvis
Lanvis is an originator product from Aspen Pharma Schweiz GmbH and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 119.05 to CHF 119.05 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Aspen Pharma Schweiz GmbH
- ATC code
- L01BB03
- IT group
- 07.16.10 Cytostatica
- Active substances
- Tioguaninum
- Preparation type
- Originator product
- On the SL since
- 15/03/1978
- Last price change
- 01/05/2013
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Tabl 40 mg | 25 Stk | CHF 94.37 | CHF 119.05 | 15/03/1978 | A | 7680378900145 |
Limitation
No limitation is recorded on the SL for this preparation.
FAQ
Is Lanvis covered by Swiss health insurance?
Yes. Lanvis is on the FOPH Specialities List, so Swiss mandatory health insurance reimburses it within the authorised indication. You still pay the deductible and a co-payment of 10 per cent.
What does Lanvis cost in Switzerland?
The public price is the maximum price set by the FOPH and for Lanvis ranges from CHF 119.05 to CHF 119.05 per pack. The ex-factory price ranges from CHF 94.37 to CHF 94.37. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages